WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Softer economic data call for quick, decisive actionMacao's electoral affairs commission for chief executive election takes officeXi extends Spring Festival greetings to all ChineseCPC Leadership Discusses Draft Gov't work ReportCPC Leadership Discusses Draft Gov't work ReportXi holds talks with Iranian president, eyeing new progress in tiesTourism market makes robust recovery over holidayXi, Portuguese president exchange congratulations on 45th anniversary of bilateral tiesNumber of flights gradually increasingNation's efforts to ensure food security praised
3.0145s , 6498.8359375 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Global Grandstand news portal